Fingerprint
Dive into the research topics of 'A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers
Divya Gupta, Ricky L. Owers, Mimi Kim, Dennis Yi Shin Kuo, Gloria S. Huang, Shohreh Shahabi, Gary L. Goldberg, Mark H. Einstein*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations